Drug Target Discovery through Somatic Genomics

Thursday, January 28, 2027 at 12:30 PM to 1:00 PM · 30 min. (Europe/London)
Multi-Omics Stage
Day 2 - Thursday 28th January
AI in Drug DiscoveryDrug DiscoveryMulti-Omics

Information

  • Somatic mutations in human tissues reveal signals of selection that can uncover disease-driving and disease-protective biology. 
  • Quotient Therapeutics’ platform combines spatial phenotyping, ultra-sensitive sequencing, and computational analysis to identify novel genetically-validated drug targets directly from patient tissues. 
  • Functional validation and drug discovery platforms are advancing those insights toward new therapeutic opportunities.